Status | Study |
Terminated |
Study Name: Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients Condition: Liver Neoplasms Liver Cirrhosis Carcinoma, Hepatocellular Date: 2007-05-04 Interventions: Drug: Oxaliplatin, gemcitabine, cisplatin, lipiodol Oxaliplatin, gemcitabine, cisplatin, lipiodol |
Completed |
Study Name: Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases Condition: Liver Metastases Colorectal Neoplasms Neoplasm Metastasis Date: 2007-02-23 Interventions: Drug: Talaporfin sodium LS11 ( |
Completed |
Study Name: Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer Condition: Bladder Neoplasms Date: 2006-12-01 Interventions: Drug: Mycobacterial cell wall-DNA complex 8 mg MCC, intravesical - Induction Phase (6 weekly intravesica |
Completed |
Study Name: Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Condition: Head and Neck Neoplasms Neoplasm Recurrence, Local Date: 2006-11-17 Interventions: Drug: docetaxel (XRP6976) Othe |
Active, not recruiting |
Study Name: Boost Use in Breast Conservation Radiotherapy Condition: Breast Neoplasms Date: 2005-08-29 Interventions: Procedure: Radiotherapy (boost versus no boost) |
Withdrawn |
Study Name: Gene Therapy for Prostate Cancer That Returns After Radiation Therapy Condition: Prostatic Neoplasms Neoplasm Recurrence, Local Date: 2005-05-10 Interventions: Genetic: Ad.hIL-12 Ad.hIL-12 intraprostatic injection IND |
Completed |
Study Name: Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy Condition: Lung Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, S Date: 2004-12-27 Interventions: Drug: Rhenium (Re 188 P2045, BAY86-5284) Infusion once only |
Completed |
Study Name: A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) Condition: Non-Small-Cell Lung Carcinoma Neoplasm Recurrence, Local Date: 2004-11-01 Interventions: Drug: Avastin (bevacizumab) Drug: Tarceva |
Completed |
Study Name: Study of NS-9 in Patients With Liver Metastases Condition: Liver Neoplasms Neoplasm Metastasis Date: 2004-10-08 Interventions: Drug: NS-9 [Poly I: Poly C] |